[ Price : $8.95]
FDA tells Applied Therapeutics its govorestat is on track for the 11/28 PDUFA action date and will not need to go before an adviso...[ Price : $8.95]
Smiths Medical recalls (Class 1) several lots of its Bivona Neonatal/Pediatric and Adult Tracheostomy tubes due to a manufacturing...[ Price : $8.95]
FDA approves AstraZenecas Fasenra (benralizumab) for treating adult patients with eosinophilic granulomatosis with polyangiitis.[ Price : $8.95]
Merck and Daiichi Sankyo say their HERTHENA-Lung02 Phase 3 trial evaluating patritumab deruxtecan in certain patients with locally...[ Price : $8.95]
Federal Register notice: FDA announces an 11/20-21 Digital Health Advisory Committee meeting to discuss generative artificial inte...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Considerations for Generating Clinical Evidence From Oncolo...[ Price : $8.95]
Federal Register notice: FDA classifies quantitative viral nucleic acid tests for transplant patient management into Class 2 (spec...[ Price : $8.95]
FDA publishes a guidance on integrating clinical trials into routine clinical practice.